Literature DB >> 27865111

Camelid and shark single domain antibodies: structural features and therapeutic potential.

Doreen Könning1, Stefan Zielonka1, Julius Grzeschik1, Martin Empting2, Bernhard Valldorf1, Simon Krah3, Christian Schröter3, Carolin Sellmann3, Björn Hock4, Harald Kolmar5.   

Abstract

In addition to canonical antibodies composed of heavy and light chains, the adaptive immune systems of camelids and cartilaginous fish comprise heavy-chain only isotypes (HcAb) devoid of light chains, where antigen-binding is mediated exclusively by one variable domain. Due to their inherent favorable attributes, such as high affinity and specificity for their cognate antigen, extraordinary stability, small size and, most importantly, the possibility to complement classical antibodies in terms of 'drugable' target-space, HcAb-derived entities evolved as promising candidates for biomedical applications of which many have already proven to be successful in early stage clinical trials.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27865111     DOI: 10.1016/j.sbi.2016.10.019

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  56 in total

Review 1.  mRNA: A Novel Avenue to Antibody Therapy?

Authors:  Thomas Schlake; Moritz Thran; Katja Fiedler; Regina Heidenreich; Benjamin Petsch; Mariola Fotin-Mleczek
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

2.  Molecular Origin of the Stability Difference in Four Shark IgNAR Constant Domains.

Authors:  Hong Zhou; Shengtang Liu; Xiuhua Yin; Zengpeng Li; Zaixing Yang; Ruhong Zhou
Journal:  Biophys J       Date:  2019-04-22       Impact factor: 4.033

3.  Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1.

Authors:  Junpeng Qi; Xiuling Li; Haiyong Peng; Erika M Cook; Eman L Dadashian; Adrian Wiestner; HaJeung Park; Christoph Rader
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

4.  A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement.

Authors:  Rasmus K Jensen; Rasmus Pihl; Trine A F Gadeberg; Jan K Jensen; Kasper R Andersen; Steffen Thiel; Nick S Laursen; Gregers R Andersen
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

5.  A One-Step Process for the Construction of Phage Display scFv and VHH Libraries.

Authors:  Carolin Sellmann; Lukas Pekar; Christina Bauer; Elke Ciesielski; Simon Krah; Stefan Becker; Lars Toleikis; Jonas Kügler; André Frenzel; Bernhard Valldorf; Michael Hust; Stefan Zielonka
Journal:  Mol Biotechnol       Date:  2020-04       Impact factor: 2.695

6.  Embracing diversity gives antibodies the power to bind.

Authors:  Henry J Sutton; Marion Pepper; Ian A Cockburn
Journal:  Immunol Cell Biol       Date:  2017-10-24       Impact factor: 5.126

Review 7.  Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift.

Authors:  Meghan O Altman; Davide Angeletti; Jonathan W Yewdell
Journal:  Viral Immunol       Date:  2018-01-22       Impact factor: 2.257

8.  Humanization of Camelid Single-Domain Antibodies.

Authors:  Traian Sulea
Journal:  Methods Mol Biol       Date:  2022

9.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

10.  Site-Specific Modification of Single-Chain Affinity Ligands for Fluorescence Labeling, Radiolabeling, and Bioconjugation.

Authors:  Boya Zhang; Sachith M Vidanapathirana; Colin F Greineder
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.